Cystatin C (CysC) is an independent risk factor for adverse outcomes in patients with HF across the ejection fraction (EF) spectrum.
A patient's estimated glomerular filtration rate (eGFR) remains a pillar for diagnosing chronic kidney disease (CKD) and tracking its progression. But nephrologists now recognize that eGFR values ...
A high-level overview of CyberScope Web3 Security Inc. (CYSC) stock. View (CYSC) real-time stock price, chart, news, analysis, analyst reviews and more.
Cystatin C (CysC) is an independent risk factor for adverse outcomes in patients with heart failure (HF) across the ejection fraction (EF) spectrum, according to a study published in Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results